These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19416613)

  • 1. [News from EMEA].
    Lindhardt BØ
    Ugeskr Laeger; 2009 Apr; 171(15):1257. PubMed ID: 19416613
    [No Abstract]   [Full Text] [Related]  

  • 2. [Marketing of pediatric drugs].
    Pabst JY
    Soins Pediatr Pueric; 2003; (210):18-9. PubMed ID: 12683130
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drugs for children--when temporary solutions become routine].
    Kalikstad B; Westergren T
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):930-2. PubMed ID: 16554887
    [No Abstract]   [Full Text] [Related]  

  • 4. Better medicines for children--where are we now, and where do we want to be?
    Rose K
    Br J Clin Pharmacol; 2005 Jun; 59(6):657-9. PubMed ID: 15948927
    [No Abstract]   [Full Text] [Related]  

  • 5. [Registration of new medicinal products in Europe].
    Singer E
    Onkologie; 2008; 31 Suppl 2():64-6. PubMed ID: 18487872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rimonabant: marketing authorization suspended... at last: withdrawal. Half-measures.
    Prescrire Int; 2009 Apr; 18(100):61. PubMed ID: 19585720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Old drugs, new possibilities].
    Raknes G
    Tidsskr Nor Laegeforen; 2008 Jan; 128(1):62-5. PubMed ID: 18183061
    [No Abstract]   [Full Text] [Related]  

  • 8. How to systematically evaluate immunogenicity of therapeutic proteins - regulatory considerations.
    Jahn EM; Schneider CK
    N Biotechnol; 2009 Jun; 25(5):280-6. PubMed ID: 19491045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Information on the composition of chemical preparations for sale on the Belgian market].
    Arch Belg; 1988; 46(7-8):389-95. PubMed ID: 3269207
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals.
    Reeve LM
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):181-7. PubMed ID: 19589365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Discouraging about drug therapy?].
    Reseland S
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1910-1. PubMed ID: 12830286
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug approval in Europe. The EMEA gets good grades, but has room for improvement.
    Walsh G
    Nat Biotechnol; 1999 Mar; 17(3):237-40. PubMed ID: 10096289
    [No Abstract]   [Full Text] [Related]  

  • 13. A drug defect reporting programme.
    Marigold W
    Can J Hosp Pharm; 1977; 30(5):140-1. PubMed ID: 10316502
    [No Abstract]   [Full Text] [Related]  

  • 14. Plans look askance at me-too medications.
    Carroll J
    Manag Care; 2008 Jan; 17(1):37-8, 41-2. PubMed ID: 18274313
    [No Abstract]   [Full Text] [Related]  

  • 15. Road rules for drugs: a survey of signals.
    Nat Med; 2010 Dec; 16(12):1362-3. PubMed ID: 21135833
    [No Abstract]   [Full Text] [Related]  

  • 16. Lost in translation: differences in antimicrobial indication approval policies between the United States and Europe.
    Pappas G; Ierodiakonou V; Falagas ME
    Clin Ther; 2009 Jul; 31(7):1595-603. PubMed ID: 19695409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Innovative Medicines Initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patients.
    Hunter AJ
    Drug Discov Today; 2008 May; 13(9-10):371-3. PubMed ID: 18468553
    [No Abstract]   [Full Text] [Related]  

  • 18. Former pharma pitchman: beware of new drugs. An industry insider advises considering the older options if you need a prescription. Interview by Sarah Baldauf.
    Nesi T
    US News World Rep; 2008 Nov 3-10; 145(10):64. PubMed ID: 18998444
    [No Abstract]   [Full Text] [Related]  

  • 19. [Report from abroad on side effects of drugs].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1994 Jan; 138(5):235-6. PubMed ID: 8114969
    [No Abstract]   [Full Text] [Related]  

  • 20. [Position statements regarding usage of biosimilars of Epoetins. Position paper of the Société de néphrologie, Société francophone de dialyse, and Société de néphrologie pédiatrique].
    Bouchet JL; Brunet P; Canaud B; Chanliau J; Combe C; Deray G; Houillier P; Kourilsky O; Ledneva E; Niaudet P; Ortiz JP; Pavlovic M; Ryckelynck JP; Singlas E; Verhelst D; ; ;
    Nephrol Ther; 2009 Feb; 5(1):61-6. PubMed ID: 19084489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.